英飞拓(002528) - 2024 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2024 was ¥189,676,777.82, a decrease of 43.05% compared to the same period last year[3] - The net profit attributable to shareholders was -¥6,963,581.73, representing a 97.47% increase in losses year-over-year[3] - The net profit after deducting non-recurring gains and losses was -¥32,114,457.20, an 88.49% increase in losses compared to the previous year[3] - Total operating revenue for Q3 2024 was ¥702,946,521.06, a decrease of 29% compared to ¥986,985,332.07 in Q3 2023[17] - Total operating costs for Q3 2024 were ¥829,357,050.08, down 29.4% from ¥1,174,429,146.47 in Q3 2023[17] - Net profit for Q3 2024 was a loss of ¥77,153,662.72, compared to a loss of ¥375,187,666.23 in Q3 2023, indicating an improvement[18] - The company reported a net loss attributable to shareholders of ¥76,499,123.29 in Q3 2024, an improvement from a loss of ¥374,524,486.64 in Q3 2023[18] - The total comprehensive loss for Q3 2024 was -¥80,394,710.64, compared to -¥365,037,195.89 in Q3 2023[18] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,589,317,153.45, down 11.75% from the end of the previous year[3] - The company’s total liabilities increased significantly, with current liabilities due within one year rising by 312.91%[7] - Current assets decreased to CNY 1,843,314,917.70 from CNY 2,183,401,532.94, a decline of approximately 15.6% year-over-year[14] - Total liabilities decreased to CNY 2,197,189,983.75 from CNY 2,542,817,385.88, a decrease of about 13.6%[15] - Owner's equity increased to CNY 392,127,169.70 from CNY 391,367,936.46, a slight increase of approximately 0.2%[15] Cash Flow - The company's cash flow from operating activities was -¥33,940,597.54, a decline of 111.98% compared to the previous year[9] - The net cash flow from operating activities was -33,940,597.54, a significant decrease compared to 283,374,214.27 in the previous year[19] - Total cash inflow from operating activities was 1,073,982,220.00, down from 1,978,567,158.92 year-over-year[19] - Cash outflow from operating activities totaled 1,107,922,817.54, compared to 1,695,192,944.65 in the same period last year[19] - Cash flow from investing activities showed a net outflow of -14,712,225.61, a decline from 264,201,616.20 in the previous year[19] - Cash inflow from financing activities was 252,216,480.75, down from 739,377,766.32 year-over-year[20] - The net cash flow from financing activities was -113,811,502.38, compared to -657,895,814.31 in the previous year[20] - The ending balance of cash and cash equivalents was 115,696,891.40, down from 242,353,967.56 at the end of the previous year[20] Shareholder Information - The total number of common shareholders at the end of the reporting period is 80,458[10] - The largest shareholder, Shenzhen Investment Holdings, holds 26.35% of shares, totaling 315,831,160 shares[10] - The second-largest shareholder, Zhaohuai Liu, holds 16.29% of shares, totaling 195,320,972 shares[10] - The company has a total of 10 major shareholders, with the top three holding over 58% of the shares[10] Operational Updates - The company is currently undergoing a correction of prior accounting errors, with disclosure expected by December 31, 2024[11] - The company has been issued a warning due to an internal control audit report that could not express an opinion, leading to a change in stock designation to "ST Yingfit"[12] - The construction progress of the Xi'an Weibei Comprehensive Hospital project is approximately 51%, with no new developments expected until management transfer procedures are completed[12] - The company has not reported any changes in the participation of major shareholders in margin trading activities[11] - The stock trading limit has been reduced from 10% to 5% following the risk warning[12] Research and Development - Research and development expenses for the period were ¥53,930,283.23, a decrease of 25.14% year-over-year[8] - Research and development expenses decreased to ¥53,930,283.23 in Q3 2024 from ¥72,038,438.09 in Q3 2023, a reduction of 25.2%[17] Financial Ratios - The weighted average return on equity was -1.92%, a decrease of 24.85% compared to the same period last year[3] - Basic and diluted earnings per share for Q3 2024 were both -0.0638, compared to -0.3124 in Q3 2023[18] - The company experienced a significant reduction in financial expenses, with interest expenses decreasing to ¥26,282,582.90 from ¥41,185,575.80 year-over-year[17]